![Finn M. Ulrich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Finn M. Ulrich
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 53 | |
Millimed A/S
![]() Millimed A/S Medical/Nursing ServicesHealth Services Millimed A/S develops treatment solutions for vascular disease. The company also develops next generation alternatives for site specific drug and agent elution. It provides electro-spinning programs to support regeneration of vessels in diseased and abnormal vasculature. Millimed was founded in May 2004 and is headquartered in Roskilde, Denmark
6
| Extinct | Medical/Nursing Services | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Finn M. Ulrich tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Technical University of Denmark | College/University | Chairman Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Copenhagen Business School | College/University | Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Masters Business Admin Graduate Degree Graduate Degree Graduate Degree | |
Novo Holdings AS (Denmark)
![]() Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Chairman President Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Novo Nordisk Fonden
![]() Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chairman Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Novo Nordisk, Inc.
![]() Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO President President Director of Finance/CFO Director/Board Member | |
LEO Pharma A/S
![]() LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
Symphogen A/S
![]() Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Founder Director/Board Member Chief Executive Officer Founder Director/Board Member Chief Executive Officer | |
University of Aarhus | College/University | Doctorate Degree Graduate Degree Director/Board Member Graduate Degree Graduate Degree Graduate Degree | |
Scandinavian International Management Institute | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Novo Ventures 1 A/S
![]() Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chairman Private Equity Investor Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
ALK-ABELLÓ A/S | Biotechnology | Chief Executive Officer Chairman Director/Board Member Director/Board Member Director/Board Member | |
ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Founder Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
NNIT A/S | Information Technology Services | Director/Board Member Chairman Director/Board Member Corporate Officer/Principal | |
CURASIGHT A/S | Medical Specialties | Director/Board Member Chairman Chief Operating Officer | |
Novo Holdings A/S (Investment Company)
![]() Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Director of Finance/CFO Chairman Corporate Officer/Principal | |
BIOPORTO A/S | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Ferring Pharmaceuticals A/S
![]() Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chief Executive Officer President Corporate Officer/Principal | |
BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Maxygen, Inc.
![]() Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Southern Denmark | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
Novo Nordisk North America, Inc. | Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal | ||
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
University of London | College/University | Corporate Officer/Principal Graduate Degree | |
Antag Therapeutics ApS
![]() Antag Therapeutics ApS Pharmaceuticals: MajorHealth Technology Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Novo Nordisk Region Europe A/S
![]() Novo Nordisk Region Europe A/S Financial ConglomeratesFinance Novo Nordisk Region Europe A/S holds ownership interests in other companies to undertake investment and financing activities. It offers service on an operational basis, including the placement of capital in companies and real estate. The company was founded September 14, 2001 and is headquartered in Bagsvaerd, Denmark. | Financial Conglomerates | Chairman Chairman | |
Novo Nordisk Region Aameo & Latam A/S
![]() Novo Nordisk Region Aameo & Latam A/S Financial ConglomeratesFinance Novo Nordisk Region International Operations A/S holds ownership interests in companies that operates within investment and financing activities. The firm also invests capital in companies and real estate. The company was founded in January 1, 2002 and is headquartered in Bagsvaerd, Denmark. | Financial Conglomerates | Chairman Chairman | |
University of Lund | College/University | Corporate Officer/Principal Graduate Degree | |
INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Dansk Erhverv
![]() Dansk Erhverv Miscellaneous Commercial ServicesCommercial Services Dansk Erhverv is a business organization and employer association representing one of the world's most powerful business communities. The private company is based in Copenhagen, Denmark, and has subsidiaries in Denmark. With a membership of 18,000 companies and over 100 industry associations, the organization works daily to promote Denmark as the best country in the world to do business. The Danish company was founded by Tom Sten Behrens-Sørensen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
GN STORE NORD A/S | Telecommunications Equipment | Chief Executive Officer Director/Board Member | |
Leo Pharma, Inc.
![]() Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Drugstore Chains | Director/Board Member Chairman | |
GN Hearing A/S
![]() GN Hearing A/S Medical SpecialtiesHealth Technology GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark. | Medical Specialties | Chief Executive Officer Director/Board Member | |
International Institute for Management Development | College/University | Masters Business Admin Masters Business Admin | |
FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Aurigene Discovery Technologies Ltd.
![]() Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Biotechnology | Director/Board Member Director/Board Member | |
RSP Systems A/S
![]() RSP Systems A/S Medical SpecialtiesHealth Technology RSP Systems A/S provides non-invasive solutions for sugar and insulin blood level measurements. Its products are used to make measurements of molecules in terms of identification and quantities. The company was founded by Olav Storm Kjestrup, Stefan Banke, and Morten Henneberg in May 2006 and is headquartered in Odense, Denmark | Medical Specialties | Director/Board Member Chairman | |
Svenskt Näringsliv
![]() Svenskt Näringsliv Miscellaneous Commercial ServicesCommercial Services Svenskt Näringsliv provides consulting services. It focuses on protection, support, and promotion of the interests of businesses. The firm provides its members with knowledge in a number of areas including labor market and law, taxes, corporate law and intellectual property, economics and macro analysis, constitutional and legal protection, security and risk management, and trade policy. The company was founded on March 29, 2001 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Kanyos Bio, Inc.
![]() Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AP MOLLER MAERSK | Marine Shipping | Corporate Officer/Principal Corporate Officer/Principal | |
NNE A/S
![]() NNE A/S Engineering & ConstructionIndustrial Services Part of Novo Nordisk A/S, NNE A/S is a Danish company that supplies systems, consultancy and engineering services. The company is based in Soborg, Denmark. | Engineering & Construction | Director/Board Member Chairman | |
Arts Biologics A/S | Director/Board Member Chief Executive Officer |
Statistiche
Distribuzione geografica
Danimarca | 37 |
Stati Uniti | 8 |
Svezia | 3 |
Norvegia | 2 |
Regno Unito | 2 |
Settori
Health Technology | 25 |
Consumer Services | 10 |
Finance | 6 |
Commercial Services | 4 |
Miscellaneous | 2 |
Posizioni
Director/Board Member | 382 |
Corporate Officer/Principal | 151 |
Chairman | 137 |
Independent Dir/Board Member | 84 |
Chief Executive Officer | 63 |
Contatti più connessi
Insiders | |
---|---|
Seppo Olavi Mäkinen | 45 |
Jack Nielsen | 38 |
Sten Scheibye | 31 |
Anders Hedegaard | 30 |
Jesper Brandgaard | 28 |
Bruce Carter | 25 |
Jens Jesper Ovesen | 25 |
Anker Gunvald Lundemose | 25 |
Martin Olin | 25 |
Anna Héléne Barnekow | 24 |
Steen Riisgaard | 24 |
Thomas Dyrberg | 24 |
Jan Ulf Sigvar J. Johansson | 23 |
Peter Helt Jacobsen Haahr | 21 |
Thomas Feldthus | 20 |
- Borsa valori
- Insiders
- Finn M. Ulrich
- Connessioni Società